PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1616591

Junctioning adjacent fields using border films and table top measurements.

D L Galinsky·W F Hartsell
View original source ↗Export metadata ↓

Abstract

We present a technique for matching adjacent treatment fields over the spine. Our approach relies on identifying vertebral bodies and correlating their position to the table top markings present on the simulator table. The vertebral body levels are verified with films taken with the isocenter at the borders (nondivergent border films) so the "true" borders are identified. This is in contrast to using the usual divergent films, which may misrepresent the field borders with respect to the vertebral body level. An additional space between fields may be added as a precaution against overlap.

Explore related subjects

Hodgkin DiseaseHumansRadiotherapyRadiotherapy DosageJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D L Galinsky, W F Hartsell. 1992. Junctioning adjacent fields using border films and table top measurements.. https://doi.org/10.1016/0958-3947(92)90013-6

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications.

The transcription factor NF-kappaB is a tightly regulated positive mediator of T- and B-cell development, proliferation, and survival. The controlled activity of NF-kappaB is required for the coordination of physiologic immune responses. However, constitutive NF-kappaB activation can promote continuous lymphocyte proliferation and survival and has recently been recognized as a critical pathogenetic factor in lymphoma. Various molecular events lead to deregulation of NF-kappaB signaling in Hodgkin disease and a variety of T- and B-cell non-Hodgkin lymphomas either up-stream or downstream of the central IkappaB kinase. These alterations are prerequisites for lymphoma cell cycling and blockage of apoptosis. This review provides an overview of the NF-kappaB pathway and discusses the mechanisms of NF-kappaB deregulation in distinct lymphoma entities with defined aberrant pathways: Hodgkin lymphoma (HL), diffuse large B-cell lymphoma (DLBCL), mucosa-associated lymphoid tissue (MALT) lymphoma, primary effusion lymphoma (PEL), and adult T-cell lymphoma/leukemia (ATL). In addition, we summarize recent data that validates the NF-kappaB signaling pathway as an attractive therapeutic target in T- and B-cell malignancies.

Hodgkin Disease↗